Literature DB >> 33074341

Features and Risk Factors for Paraneoplastic Autoimmune Multiorgan Syndrome in 145 Chinese Patients.

Mingyue Wang1, Furong Li, Xintong Wang, Xue Wang, Rui Wang, Yinmo Yang, Jian Li, Shijie Zhang, Weiming Huang, Yujun Dong, Xiangdong Mu, Ting Li, Kaiwen Ni, Xixue Chen, Xuejun Zhu.   

Abstract

Paraneoplastic autoimmune multiorgan syndrome is a complex and deadly disease. We retrospectively reviewed the clinical features and risk factors for paraneoplastic autoimmune multiorgan syndrome in 145 Chinese patients. The most common neoplasm was Castleman disease (56%), and patients with Castleman disease tended to be younger (≤ 42 years old: 83% vs. 29%) and to have a greater proportions of lichen planus-like lesions (47% vs. 27%) and bronchiolitis obliterans (49% vs. 29%), compared to other neoplasm-associated patients. Among all 145 patients in the study, the survival rates were 84% at 1 year, 65% at 3 years, and 54% at 5 years. Kaplan-Meier curve analysis revealed that mortality was associated with older age (> 42 years), neoplasm type, labial lesions, and larger skin lesion area (> 17.5% of the body surface area). However, only older age and larger skin lesion area were independent factors associated with mortality in multivariate analysis. We suggest that patients with Castleman disease and paraneoplastic autoimmune multiorgan syndrome have many unique characteristics and the underlying risk factors for death require further exploration.

Entities:  

Keywords:  Castleman disease; bronchiolitis obliterans; risk factors; survival rate; paraneoplastic autoimmune multiorgan syndrome

Mesh:

Year:  2020        PMID: 33074341      PMCID: PMC9309820          DOI: 10.2340/00015555-3673

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  35 in total

1.  The mechanism of respiratory failure in paraneoplastic pemphigus.

Authors:  H C Nousari; R Deterding; H Wojtczack; S Aho; J Uitto; T Hashimoto; G J Anhalt
Journal:  N Engl J Med       Date:  1999-05-06       Impact factor: 91.245

2.  Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus.

Authors:  Yuri Choi; Kyung-Hwa Nam; Jee-Bum Lee; Jun Young Lee; Chull-Wan Ihm; Sang Eun Lee; Sang Ho Oh; Takashi Hashimoto; Soo-Chan Kim
Journal:  J Dermatol       Date:  2012-09-03       Impact factor: 4.005

Review 3.  Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment.

Authors:  Saritha Kartan; Vivian Y Shi; Ashley K Clark; Lawrence S Chan
Journal:  Am J Clin Dermatol       Date:  2017-02       Impact factor: 7.403

4.  Improved outcomes after complete resection of underlying tumors for patients with paraneoplastic pemphigus: a single-center experience of 22 cases.

Authors:  Jun Zhang; Qi-lu Qiao; Xi-xue Chen; Ping Liu; Jian-xing Qiu; Hu Zhao; Jian-xun Zhao; Yu-cun Liu; Yuan-lian Wan
Journal:  J Cancer Res Clin Oncol       Date:  2011-02       Impact factor: 4.553

5.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.

Authors:  G J Anhalt; S C Kim; J R Stanley; N J Korman; D A Jabs; M Kory; H Izumi; H Ratrie; D Mutasim; L Ariss-Abdo
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

6.  Clinical and immunological findings in 104 cases of paraneoplastic pemphigus.

Authors:  A Ohzono; R Sogame; X Li; K Teye; A Tsuchisaka; S Numata; H Koga; T Kawakami; D Tsuruta; N Ishii; T Hashimoto
Journal:  Br J Dermatol       Date:  2015-11-14       Impact factor: 9.302

7.  Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.

Authors:  Elise Ouedraogo; Jeremy Gottlieb; Adèle de Masson; Clémence Lepelletier; Marie Jachiet; Camille Salle de Chou; Lionel Galicier; Martine Bagot; Sylvie Chevret; Jean-David Bouaziz
Journal:  J Am Acad Dermatol       Date:  2019-04-10       Impact factor: 11.527

Review 8.  Paraneoplastic autoimmune multiorgan syndrome: 20 years after.

Authors:  Annette Czernik; Michael Camilleri; Mark R Pittelkow; Sergei A Grando
Journal:  Int J Dermatol       Date:  2011-08       Impact factor: 2.736

9.  Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.

Authors:  Jing Li; Ding-fang Bu; Yong-chu Huang; Xue-jun Zhu
Journal:  Chin Med J (Engl)       Date:  2009-03-05       Impact factor: 2.628

10.  Unicentric castleman disease complicated by paraneoplastic bronchiolitis obliterans and pemphigus.

Authors:  Hassan A Raza; Brandon T Nokes; Allison C Rosenthal; Aaron R Mangold; Katalin Kelemen; Clinton E Jokerst; Rodrigo Cartin-Ceba
Journal:  Respir Med Case Rep       Date:  2018-08-10
View more
  1 in total

1.  Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report.

Authors:  Birao Fan; Mingyue Wang
Journal:  Acta Derm Venereol       Date:  2022-06-09       Impact factor: 3.875

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.